2020 Webinar: Chronic Hepatitis C 101: The Basics-Chronic Hepatitis C 101: The Basics

Video Transcription

Video Summary

The video transcript discusses the basics of treatment for hepatitis C. The presenters provide information on the epidemiology of hepatitis C, screening strategies, and the current treatment options. Hepatitis C is a global health problem, with an estimated 71 million people worldwide living with the disease. It can lead to liver damage and other complications if left untreated. Treatment options have significantly improved in recent years, with direct-acting antiviral medications achieving cure rates of over 95%. The presenters highlight specific treatment regimens such as Epclusa and Maviret, which are one pill a day for 12 weeks, and are effective for all genotypes of hepatitis C. The safety profile of these medications is generally good, with few side effects reported. The presenters note that screening for hepatocellular carcinoma should continue after treatment, especially in patients with advanced fibrosis or cirrhosis. Overall, the webinar emphasizes the effectiveness of current treatment options and the importance of screening and treating hepatitis C to prevent liver-related complications and reduce transmission of the virus.

Asset Caption

Moderator: Brian L. Pearlman, MD, FAASLD
Presenters: Lisa Catalli, MSN, NP-BC and Natarajan Ravendhran, MD, MBA, AGAF, FACG, FAASLD

Keywords

hepatitis C

treatment

epidemiology

screening strategies

direct-acting antiviral medications

cure rates

Epclusa

Maviret

complications

transmission